Academic Content and Language Evaluation of This Article
Academic Rules and Norms of This Article
Supplementary Materials of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (12676)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Nov 27, 2021 (publication date) through May 10, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Biological Chemistry
ISSN
1949-8454
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Ikeda Y, Nagase N, Tsuji A, Kitagishi Y, Matsuda S. Neuroprotection by dipeptidyl-peptidase-4 inhibitors and glucagon-like peptide-1 analogs via the modulation of AKT-signaling pathway in Alzheimer’s disease. World J Biol Chem 2021; 12(6): 104-113 [PMID: 34904048 DOI: 10.4331/wjbc.v12.i6.104] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v12/i6/104.htm |
| Number | Citing Articles |
| 1 |
Dipeptidyl peptidase 4(DPP4) inhibitors stride up the management of Parkinson's disease. European Journal of Pharmacology 2023; 939: 175426 doi: 10.1016/j.ejphar.2022.175426
|
| 2 |
Moeka Nakashima, Naoko Suga, Sayuri Yoshikawa, Satoru Matsuda. Caveolae with GLP-1 and NMDA Receptors as Crossfire Points for the Innovative Treatment of Cognitive Dysfunction Associated with Neurodegenerative Diseases. Molecules 2024; 29(16): 3922 doi: 10.3390/molecules29163922
|
| 3 |
Toshiyuki Murai, Satoru Matsuda. The Chemopreventive Effects of Chlorogenic Acids, Phenolic Compounds in Coffee, against Inflammation, Cancer, and Neurological Diseases. Molecules 2023; 28(5): 2381 doi: 10.3390/molecules28052381
|
| 4 |
Hye-Yeon Park, Young-Kyoung Ryu, Ga Seul Lee, Jun Go, Ju-Eun Kim, Kyeong-Seon Min, Chul-Ho Lee, Jeong Hee Moon, Kyoung-Shim Kim. Sitagliptin attenuates L-dopa-induced dyskinesia by regulating mitochondrial proteins and neuronal activity in a 6-OHDA-induced mouse model of Parkinson’s disease. Journal of Neural Transmission 2025; doi: 10.1007/s00702-025-02907-1
|
| 5 |
Bárbara Teruel-Peña, José Luís Gómez-Urquiza, Nora Suleiman-Martos, Isabel Prieto, Francisco José García-Cózar, Manuel Ramírez-Sánchez, Carmen Fernández-Martos, Germán Domínguez-Vías. Systematic Review and Meta-Analyses of Aminopeptidases as Prognostic Biomarkers in Amyotrophic Lateral Sclerosis. International Journal of Molecular Sciences 2023; 24(8): 7169 doi: 10.3390/ijms24087169
|
| 6 |
Maanvi Dhureja, Rahul Deshmukh. Impact of alogliptin on lipopolysaccharide-induced experimental Parkinson's disease: Unrevealing neurochemical and histopathological alterations in rodents.. European Journal of Pharmacology 2024; 975: 176635 doi: 10.1016/j.ejphar.2024.176635
|
| 7 |
Agnieszka Skibska, Renata Perlikowska. Natural Plant Materials as a Source of Neuroprotective Peptides. Current Medicinal Chemistry 2024; 31(31): 5027 doi: 10.2174/0929867331666230703145043
|
| 8 |
Sayuri Yoshikawa, Kurumi Taniguchi, Haruka Sawamura, Yuka Ikeda, Ai Tsuji, Satoru Matsuda. A New Concept of Associations between Gut Microbiota, Immunity and Central Nervous System for the Innovative Treatment of Neurodegenerative Disorders. Metabolites 2022; 12(11): 1052 doi: 10.3390/metabo12111052
|
| 9 |
Oytun Erbas, İlknur Altuntaş, Pemra Nesil, Hadi Sasani, Mehtap Odabaşı. Rare Neurodegenerative Disorders - New Insights [Working Title]. 2023; doi: 10.5772/intechopen.109967
|
| 10 |
Moeka Nakashima. Caveolae with serotonin and NMDA receptors as promising targets for the treatment of Alzheimer’s disease. International Journal of Physiology, Pathophysiology and Pharmacology 2024; 16(5): 96 doi: 10.62347/MTWV3745
|
| 11 |
Kunjian Yang, Qian Li, Yushuang Ruan, Yuanpeng Xia, Zhi Fang. Caveolae-Mediated Transcytosis and Its Role in Neurological Disorders. Biomolecules 2025; 15(4): 456 doi: 10.3390/biom15040456
|
| 12 |
Jie Meng, Rui Yan, Chen Zhang, Xueyan Bai, Xingsheng Yang, Yu Yang, Tao Feng, Xin Liu. Dipeptidyl peptidase-4 inhibitors alleviate cognitive dysfunction in type 2 diabetes mellitus. Lipids in Health and Disease 2023; 22(1) doi: 10.1186/s12944-023-01985-y
|
| 13 |
Jean-baptiste Bonnet, Axelle Trupheme Durieux, Sarah Tournayre, Lucile Marty, Ariane Sultan, Antoine Avignon. Semaglutide as a potential treatment for obesity in Smith-Kingsmore syndrome (SKS) patients: A mosaic mutation case report. Obesity Research & Clinical Practice 2024; 18(2): 159 doi: 10.1016/j.orcp.2024.03.009
|
| 14 |
Hans-Gert Bernstein, Gerburg Keilhoff, Henrik Dobrowolny, Johann Steiner. The many facets of CD26/dipeptidyl peptidase 4 and its inhibitors in disorders of the CNS – a critical overview. Reviews in the Neurosciences 2023; 34(1): 1 doi: 10.1515/revneuro-2022-0026
|
| 15 |
Nassima Oumata, Kui Lu, Yuou Teng, Christian Cavé, Yu Peng, Hervé Galons, Bernard P. Roques. Molecular mechanisms in Alzheimer's disease and related potential treatments such as structural target convergence of antibodies and simple organic molecules. European Journal of Medicinal Chemistry 2022; 240: 114578 doi: 10.1016/j.ejmech.2022.114578
|
| 16 |
Mohammed Alrouji, Hayder M. Al-Kuraishy, Ali I. Al-Gareeb, Athanasios Alexiou, Marios Papadakis, Hebatallah M. Saad, Gaber El-Saber Batiha. The potential role of human islet amyloid polypeptide in type 2 diabetes mellitus and Alzheimer’s diseases. Diabetology & Metabolic Syndrome 2023; 15(1) doi: 10.1186/s13098-023-01082-1
|